Evaluation of administrative case definitions for chronic kidney disease in children.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
02 2020
Historique:
received: 02 05 2019
accepted: 05 09 2019
revised: 13 08 2019
pubmed: 3 10 2019
medline: 26 2 2021
entrez: 3 10 2019
Statut: ppublish

Résumé

Administrative data is increasingly used for chronic disease surveillance; however, its validity to define cases of chronic kidney disease (CKD) in children is unknown. We sought to evaluate the performance of case definitions for CKD in children. We utilized population-based administrative data from the Manitoba Center for Health Policy to evaluate the validity of algorithms based on a combination of hospital claims, outpatient physician visits, and pharmaceutical use over 1-3 years in children <18 years of age. Algorithms were compared with a laboratory-based definition (estimated glomerular filtration rate < 90 ml/min/1.73 m All algorithms evaluated had very low sensitivity (0.20-0.39) and moderate positive predictive value (0.52-0.68). Algorithms had excellent specificity (0.98-0.99) and negative predictive value (0.96-0.97). Receiver operating characteristic (ROC) curves indicate fair accuracy (0.60-0.68). Sensitivity improved with increasing years of data. One or more physician claims and one or more prescriptions over 3 years had the highest sensitivity and ROC. The sensitivity of administrative data algorithms for CKD is unacceptably low for a screening test. Specificity is excellent; therefore, children without CKD are correctly identified. Alternate data sources are required for population-based surveillance of this important chronic disease.

Identifiants

pubmed: 31578037
doi: 10.1038/s41390-019-0595-1
pii: 10.1038/s41390-019-0595-1
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-575

Références

Arora, P. et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185, E417–E423 (2013).
doi: 10.1503/cmaj.120833
Coresh, J. et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J. Am. Soc. Nephrol. 16, 180–188 (2005).
doi: 10.1681/ASN.2004070539
Arce, C. M. et al. Kidney function and cardiovascular events in postmenopausal women: the impact of race and ethnicity in the women’s health initiative. Am. J. Kidney Dis. 67, 198–208 (2016).
doi: 10.1053/j.ajkd.2015.07.020
Goldfarb-Rumyantzev, A. S., Gautam, S., Dong, N. & Brown, R. S. Prediction model and risk stratification tool for survival in patients with CKD. Kidney Int. Rep. 3, 417–425 (2018).
doi: 10.1016/j.ekir.2017.11.010
Wong, S. P. et al. Decisions about renal replacement therapy in patients with advanced kidney disease in the US Department of Veterans Affairs, 2000–2011. Clin. J. Am. Soc. Nephrol. 11, 1825–1833 (2016).
doi: 10.2215/CJN.03760416
Landman, G. W. et al. Health-related quality of life and mortality in a general and elderly population of patients with type 2 diabetes (ZODIAC-18). Diabetes Care 33, 2378–2382 (2010).
doi: 10.2337/dc10-0979
Klarenbach, S. W., Tonelli, M., Chui, B. & Manns, B. J. Economic evaluation of dialysis therapies. Nat. Rev. Nephrol. 10, 644–652 (2014).
doi: 10.1038/nrneph.2014.145
Canadian Organ Replacement Register (CORR). 2016 CORR Statistics: Treatment of End-Stage Organ Failure in Canada, 2005 to 2014. https://www.cihi.ca/en/canadian-organ-replacement-register-2016 (2016).
Tong, A. et al. Quality of life of young adults and adolescents with chronic kidney disease. J. Pediatr. 163, 1179–1185 e1175 (2013).
doi: 10.1016/j.jpeds.2013.04.066
Kogon, A. J. et al. Depression and its associated factors in pediatric chronic kidney disease. Pediatr. Nephrol. 28, 1855–1861 (2013).
doi: 10.1007/s00467-013-2497-5
Hodson, E. M., Willis, N. S., Craig, J. C. Growth hormone for children with chronic kidney disease. Cochrane Database Syst Rev 2, CD003264 (2012).
Shroff, R. & Ledermann, S. Long-term outcome of chronic dialysis in children. Pediatr. Nephrol. 24, 463–474 (2009).
doi: 10.1007/s00467-007-0700-2
Falkner, B. Hypertension in children and adolescents: epidemiology and natural history. Pediatr. Nephrol. 25, 1219–1224 (2010).
doi: 10.1007/s00467-009-1200-3
Cash, A. et al. Childhood obesity: epidemiology, comorbid conditions, psychological ramifications, and clinical recommendations. J. Okla. State Med. Assoc. 97, 428–433 (2004). quiz 434-435.
pubmed: 15552239
Amed, S. et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children: a prospective national surveillance study. Diabetes Care 33, 786–791 (2010).
doi: 10.2337/dc09-1013
Brenner, B. M. et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861–869 (2001).
doi: 10.1056/NEJMoa011161
Akbari, A. et al. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management. Am. J. Kidney Dis. 65, 177–205 (2015).
doi: 10.1053/j.ajkd.2014.10.013
Lewis, E. J. et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851–860 (2001).
doi: 10.1056/NEJMoa011303
Tonelli, M. et al. Methods for identifying 30 chronic conditions: application to administrative data. BMC Med. Inform. Decis. Mak. 15, 31 (2015).
doi: 10.1186/s12911-015-0155-5
Dart, A. B. et al. Validation of a pediatric diabetes case definition using administrative health data in manitoba, Canada. Diabetes Care 34, 898 (2011).
doi: 10.2337/dc10-1572
Hux, J. E., Ivis, F., Flintoft, V. & Bica, A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25, 512–516 (2002).
doi: 10.2337/diacare.25.3.512
Friedman, M. Y. et al. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study. Clin. Epidemiol. 10, 671–681 (2018).
doi: 10.2147/CLEP.S151339
Ronksley, P. E. et al. Validating a case definition for chronic kidney disease using administrative data. Nephrol. Dial. Transpl. 27, 1826–1831 (2012).
doi: 10.1093/ndt/gfr598
Vlasschaert, M. E. et al. Validity of administrative database coding for kidney disease: a systematic review. Am. J. Kidney Dis. 57, 29–43 (2011).
doi: 10.1053/j.ajkd.2010.08.031
Chartier, M. J. et al. Prevalence, socio-demographic characteristics, and comorbid health conditions in pre-dialysis chronic kidney disease: results from the Manitoba chronic kidney disease cohort. BMC Nephrol. 19, 255 (2018).
doi: 10.1186/s12882-018-1058-3
Hoste, L. et al. A new equation to estimate the glomerular filtration rate in children, adolescents and young adults. Nephrol. Dial. Transpl. 29, 1082–1091 (2014).
doi: 10.1093/ndt/gft277
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 3, 1–150 (2013).
Schwartz, G. J. et al. New equations to estimate GFR in children with CKD. J. Am. Soc. Nephrol. 20, 629–637 (2009).
doi: 10.1681/ASN.2008030287
De Souza, V. et al. Can the height-independent Pottel eGFR equation be used as a screening tool for chronic kidney disease in children? Eur. J. Pediatr. 174, 1225–1235 (2015).
doi: 10.1007/s00431-015-2523-7
Pottel, H., Hoste, L. & Martens, F. A simple height-independent equation for estimating glomerular filtration rate in children. Pediatr. Nephrol. 27, 973–979 (2012).
doi: 10.1007/s00467-011-2081-9
Canadian Organ Replacement Register (CORR). High Risk and High Cost Focus on Opportunities to Reduce Hospitalizations of Dialysis Patients. https://secure.cihi.ca/estore/productFamily.htm?locale=en&pf=PFC3380&lang=en (2017).
Calderon-Margalit, R., Skorecki, K. & Vivante, A. History of childhood kidney disease and risk of adult end-stage renal disease. N. Engl. J. Med. 378, 1751–1752 (2018).
doi: 10.1056/NEJMoa1700993
Benchimol, E. I. et al. Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases. Am. J. Gastroenterol. 112, 1120–1134 (2017).
doi: 10.1038/ajg.2017.97

Auteurs

Allison Dart (A)

University of Manitoba, Winnipeg, MB, R3T 2N2, Canada. adart@hsc.mb.ca.

Mariette Chartier (M)

University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.
Manitoba Center for Health Policy, Winnipeg, MB, Canada.

Paul Komenda (P)

University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.

Randy Walld (R)

Manitoba Center for Health Policy, Winnipeg, MB, Canada.

Ina Koseva (I)

Manitoba Center for Health Policy, Winnipeg, MB, Canada.

Charles Burchill (C)

Manitoba Center for Health Policy, Winnipeg, MB, Canada.

Navdeep Tangri (N)

University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH